Related Experiment Video
Updated: Jul 1, 2026

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
Hypoxia induced DNMT3B and SHP2 signaling promoted HCC via suppressing P53 and MYH11 protein expression
Hongxun Ruan1, Wei Huang1, Yanle Fang1
1The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Objective:
This work aims to analyze the intricate process via which CBFβ-MYH11 facilitates the suppression of hepatocellular carcinoma in hypoxic environments.
Methods:
Three independent HCC cohorts including TCGA-LIHC, GSE14520 and ICGC LIRI-JP were enrolled. Gene correlation analysis, hypoxia-based expression comparison and prognostic stratification analysis were performed. A composite HIF1A/AKT/SHP2/DNMT3B/P53/MYH11 axis score was established to evaluate clinical prognostic value. Bioinformatics analysis was utilized to examine differentially expressed genes in hepatocellular carcinoma. In nude mouse models, tumor volume, tumor cross-sectional area, methylation levels, protein expression, vascular development, scratch assay, invasion assay, chromatin immunoprecipitation, and co-immunoprecipitation were quantitatively assessed. We used methods including HE staining, immunohistochemistry, phosphor-PCR, Western blot, angiogenesis tests, migration assays, and invasion assays.
Results:
Multi-cohort analysis revealed a stable negative correlation between DNMT3B and MYH11. High HIF1A expression was accompanied by DNMT3B upregulation and MYH11 silencing. Patients in the high axis score group exhibited markedly shorter overall survival, and the axis score served as an independent adverse prognostic risk factor. Bioinformatics analysis reveals MYH11-specific expression in hepatocellular carcinoma. There were clear differences between Huh-7-NC-CBFβ-MYH11 and Huh-7-OE-CBFβ-MYH11 when they were compared. Huh-7-OE-CBFβ-MYH11 showed a smaller tumor volume, less vascular density, fewer invasion cells, a shorter migration distance, and less vascular development. The expression of MMP2, VEGF, and HIF1α showed a decrease, while RUNX1 expression increased. The introduction of an AKT inhibitor in hypoxic conditions resulted in a more pronounced increase in P53 and CBFβ-MYH11 protein expression compared to the SHP2 inhibitor. AKT inhibitors eliminated differences in DNMT3B, HIF1α, and MMP2 expression between normoxia and hypoxia.
Conclusion:
In hypoxic conditions, CBFβ-MYH11 regulates the AKT/DNMT3B/SHP2 pathway to modulate variations in P53 expression, ultimately hindering the progression of hepatocellular carcinoma.
Insights
CBFβ-MYH11 suppresses hepatocellular carcinoma (HCC) by regulating the AKT/DNMT3B/SHP2 pathway in hypoxic conditions. This pathway modulation impacts P53 expression, hindering tumor progression and improving patient prognosis in HCC.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Hepatocellular carcinoma (HCC) remains a significant global health challenge.
- Hypoxia is a critical factor influencing HCC progression and treatment resistance.
- Understanding the molecular mechanisms underlying HCC suppression is crucial for developing novel therapies.
Purpose of the Study:
- To investigate the role of CBFβ-MYH11 in suppressing hepatocellular carcinoma under hypoxic conditions.
- To elucidate the molecular pathways regulated by CBFβ-MYH11 in HCC.
- To evaluate the prognostic value of a composite molecular axis score in HCC patients.
Main Methods:
- Analysis of three independent HCC cohorts (TCGA-LIHC, GSE14520, ICGC LIRI-JP).
- Gene correlation, hypoxia-based expression, and prognostic stratification analyses.
- Establishment of a composite HIF1A/AKT/SHP2/DNMT3B/P53/MYH11 axis score.
- In vivo studies using nude mouse models with quantitative assessments of tumor characteristics and molecular markers.
- In vitro assays including scratch and invasion assays, Western blot, and immunoprecipitation.
Main Results:
- A negative correlation between DNMT3B and MYH11 was observed, with high HIF1A correlating with DNMT3B upregulation and MYH11 silencing.
- A high composite axis score was associated with shorter overall survival and identified as an independent adverse prognostic factor.
- CBFβ-MYH11 overexpression in HCC cells reduced tumor volume, vascular density, invasion, and migration.
- CBFβ-MYH11 modulated the expression of key genes including HIF1α, VEGF, MMP2, and RUNX1.
- AKT inhibition under hypoxia significantly increased P53 and CBFβ-MYH11 expression, normalizing DNMT3B, HIF1α, and MMP2 levels.
Conclusions:
- CBFβ-MYH11 plays a crucial role in suppressing HCC progression in hypoxic environments.
- The AKT/DNMT3B/SHP2 pathway is a key target regulated by CBFβ-MYH11 to modulate P53 expression.
- The findings highlight CBFβ-MYH11 as a potential therapeutic target for HCC, particularly in hypoxic tumors.
Related Concept Videos
Abnormal Proliferation
Regulation of Angiogenesis and Blood Supply
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Hedgehog Signaling Pathway
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle